Results 11 to 20 of about 7,783,447 (235)

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

Journal of Medical Internet Research, 2021
Background Survival analysis is a cornerstone of medical research, enabling the assessment of clinical outcomes for disease progression and treatment efficiency.
A. Lánczky, Balázs Győrffy
semanticscholar   +1 more source

Improved survival with ipilimumab in patients with metastatic melanoma.

New England Journal of Medicine, 2010
BACKGROUND An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3 study, ipilimumab--which blocks cytotoxic T-lymphocyte-associated antigen 4 to potentiate an antitumor T-cell response ...
F. Hodi, S. O'Day, D. McDermott, R. Weber, J. Sosman, J. Haanen, R. Gonzalez, C. Robert, D. Schadendorf, Jessica C Hassel, W. Akerley, A. van den Eertwegh, J. Lutzky, P. Lorigan, Julia Vaubel, G. Linette, D. Hogg, C. Ottensmeier, C. Lebbé, C. Peschel, I. Quirt, Joseph I. Clark, J. Wolchok, J. Weber, Jason Tian, M. Yellin, G. Nichol, A. Hoos, W. Urba   +28 more
semanticscholar   +1 more source

Survival of the Systems [PDF]

Trends in Ecology & Evolution, 2021
Since Darwin, individuals and more recently genes, have been the focus of evolutionary thinking. The idea that selection operates on nonreproducing, higher-level systems including ecosystems or societies, has met with scepticism. But research emphasising that natural selection can be based solely on differential persistence invites reconsideration of ...
Timothy A. Kohler, Timothy A. Kohler, Timothy A. Kohler, Richard Boyle, Timothy M. Lenton, Marten Scheffer, Michel Crucifix, Pablo A. Marquet, Pablo A. Marquet, David M. Wilkinson, David M. Wilkinson   +10 more
openaire   +4 more sources

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

New England Journal of Medicine, 2019
BACKGROUND Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advanced melanoma. We now report 5-year outcomes in the trial. METHODS We randomly
J. Larkin, V. Chiarion-Sileni, R. Gonzalez, J. Grob, P. Rutkowski, C. Lao, C. Cowey, D. Schadendorf, J. Wagstaff, R. Dummer, P. Ferrucci, M. Smylie, D. Hogg, A. Hill, I. Márquez-Rodas, J. Haanen, M. Guidoboni, M. Maio, P. Schöffski, M. Carlino, C. Lebbé, G. McArthur, P. Ascierto, G. Daniels, G. Long, L. Bastholt, J. Rizzo, Á. Balogh, A. Moshyk, F. Hodi, J. Wolchok   +30 more
semanticscholar   +1 more source

Surviving [PDF]

Feminismo/s, 2006
Borrowing Derrida’s insight in ‘Survivre’ that a text can call on us to read another text of which it makes little or no mention, this article explores some of the ways in which Cixous and Derrida reflect upon each other’s writing, including in texts ostensibly bearing no relation to the other’s work.
openaire   +3 more sources

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

New England Journal of Medicine, 2013
BACKGROUND In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted a phase 3 study of the efficacy and safety of the combination
D. V. Von Hoff, T. Ervin, F. Arena, E. Chiorean, J. Infante, M. Moore, T. Seay, S. Tjulandin, W. Ma, M. Saleh, M. Harris, M. Reni, S. Dowden, D. Laheru, N. Bahary, R. Ramanathan, J. Tabernero, M. Hidalgo, D. Goldstein, E. Van Cutsem, Xinyu Wei, J. Iglesias, M. Renschler   +22 more
semanticscholar   +1 more source

Coopeting to Survive; Surviving Coopetition

International Studies of Management & Organization, 2007
This study is based on an inductive study, and it aims to present the theoretical distinctions of the possible unintended effects caused by coopetition. The study focuses on San Benedetto SpA, an Italian drinks and bottling company that survived competition in the soft drinks and beverages industry thanks to a coopetition-driven strategy.
BONEL, ELENA, ROCCO E.
openaire   +3 more sources

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

New England Journal of Medicine, 2017
BACKGROUND Nivolumab combined with ipilimumab resulted in longer progression‐free survival and a higher objective response rate than ipilimumab alone in a phase 3 trial involving patients with advanced melanoma.
J. Wolchok, V. Chiarion-Sileni, R. Gonzalez, P. Rutkowski, J. Grob, L. Cowey, C. Lao, J. Wagstaff, D. Schadendorf, P. Ferrucci, M. Smylie, R. Dummer, A. Hill, D. Hogg, J. Haanen, M. Carlino, O. Bechter, M. Maio, I. Márquez-Rodas, M. Guidoboni, G. McArthur, C. Lebbé, P. Ascierto, G. Long, J. Cebon, J. Sosman, M. Postow, M. Callahan, D. Walker, L. Rollin, R. Bhore, S. Hodi, J. Larkin   +32 more
semanticscholar   +1 more source

Survival with ambiguity [PDF]

Journal of Economic Theory, 2015
We analyze a market populated by expected utility maximizers and smooth ambiguity-averse consumers. We study conditions under which ambiguity-averse consumers survive and affect prices in the limit. If ambiguity vanishes with time or if the economy exhibits no aggregate risk, ambiguity-averse consumers survive, but have no long-run impact on prices. In
Ani Guerdjikova, Emanuela Sciubba
openaire   +5 more sources

Pengaruh Kecerdasan Emosional Terhadap Kinerja Pegawai Yang Dimoderasi Etos Kerja (Studi Pada Dinas Perpustakaan Umum Dan Arsip Daerah Kota Malang) [PDF]

, 2022
AbstrakKrispin Agustina Moula, Program Studi Manajemen, Fakultas Ekonomi dan Bisnis, Universitas Widyagama Malang, 2022. Pengaruh Kecerdasan Emosional terhadap Kinerja Pegawai yang Dimoderasi Etos Kerja (Studi pada Dinas Perpustakaan Umum dan Arsip ...
Hermawati, Adya, Moula, Krispin Agustina, Survival, Survival   +2 more
core   +1 more source